01Aethlon Medical reported Q1 2026 earnings per share of -$4.02, missing the consensus estimate of -$3.76 by $0.26 per share on August 13, 2026.
02The stock trades at $2.93 with a market capitalization of $1.5 million, and the earnings miss puts pressure on the stock as investors reassess growth assumptions.
03The company showed significant volatility in recent quarters, with Q4 2026 beating estimates by 116.3% but Q3 2026 missing by 7.0%, indicating inconsistent performance trends.
Earnings Results
Aethlon Medical (NASDAQ:AEMD) reported quarterly earnings results on August 13, 2026 that fell short of analyst expectations.
The Healthcare company reported earnings per share of $-4.02, missing the consensus estimate of $-3.76 by $0.26 per share. Revenue came in at , meeting the estimate of .
Company Overview
Aethlon Medical's stock moved following the earnings release. The stock currently trades at $2.93 with a market capitalization of $1.5M.
Missing analyst estimates puts pressure on a stock as investors reassess their growth assumptions. The market's reaction to an earnings miss depends heavily on the magnitude of the shortfall, the company's forward guidance, and whether the miss was driven by temporary or structural factors.
Earnings reports are most useful when viewed as part of a trend rather than in isolation. Investors tracking Aethlon Medical should compare this quarter's results against both year-over-year figures and sequential performance to identify whether the business is accelerating, stabilizing, or decelerating. The earnings calendar on Smart Investors Daily tracks upcoming report dates across all publicly traded companies.